Copyright © Inderes 2011 - present. All rights reserved.
Log ind for at modtage meddelelser.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Cyxone

Mindre end 1K følgere
Overview
Investor consensus
Alle
Analyse
Selskabsmeddelelser
ViserAlle indholdstyper
Selskabsmeddelelse26.8.2024, 12.19

Cyxone AB announces last day of trading in BTA

Cyxone
Selskabsmeddelelse16.8.2024, 06.59

Cyxone AB publishes outcome of rights issue

Cyxone
Selskabsmeddelelse1.8.2024, 06.45

The subscription period in Cyxone's rights issue starts today

Cyxone

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Selskabsmeddelelse31.7.2024, 06.45

Cyxone AB publishes investment memorandum

Cyxone
Selskabsmeddelelse23.7.2024, 06.30

Cyxone: The board decides on a rights issue of a maximum of approximately SEK 23 million to finance continued development of rabeximod and T20K

Cyxone
Pressemeddelelse15.7.2024, 06.42

Cyxone provides an update on its research and development program

Cyxone
Selskabsmeddelelse22.4.2024, 08.02

Kjell Stenberg new CEO in Cyxone AB

Cyxone
Pressemeddelelse28.3.2024, 10.52

BioStock: Cyxone comments on the clinical collaboration in the UK

Cyxone
Pressemeddelelse25.3.2024, 12.44

Cyxone enters important research collaboration

Cyxone
Pressemeddelelse5.3.2024, 08.42

BioStock: Cyxone's CEO gives a status update

Cyxone
Pressemeddelelse17.1.2024, 07.45

BioStock: Cyxone identifies target protein for rabeximod

Cyxone
Pressemeddelelse15.1.2024, 09.01

Cyxone reaches important milestone regarding mechanism of action

Cyxone
Pressemeddelelse20.11.2023, 08.22

Cyxone welcomes a renewed engagement by Professor Rikard Holmdahl as Scientific Advisor

Cyxone
Selskabsmeddelelse27.10.2023, 06.29

Cyxone: Interim Report 1 January to 30 September 2023

Cyxone
Selskabsmeddelelse9.10.2023, 06.38

Cyxone receives Intention to Grant from the European Patent Office for a unitary patent of T20K

Cyxone
Pressemeddelelse27.9.2023, 07.30

BioStock Investor Meeting: Cyxone

Cyxone
Selskabsmeddelelse30.8.2023, 06.32

Cyxone: Interim Report 1 January to 30 June 2023

Cyxone
Selskabsmeddelelse29.8.2023, 17.03

Cyxone revises strategy for commercial alignment targeting valuable market opportunities

Cyxone
Selskabsmeddelelse15.6.2023, 06.30

Cyxone appoints Urban Ottosson as new CFO

Cyxone
Pressemeddelelse31.5.2023, 12.00

Cyxone receives Intention to Grant from the European Patent Office for the divisional patent of T20K

Cyxone
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Privatlivspræferencer

Inderes bruger cookies for at give en bedre brugeroplevelse og en personlig service. Ved at give samtykke til brugen af cookies kan vi udvikle en endnu bedre service og vil kunne levere indhold, der er interessant for dig.